Page last updated: 2024-08-25

1h-benzotriazole-5-carboxylic acid and Diabetes Mellitus, Type 2

1h-benzotriazole-5-carboxylic acid has been researched along with Diabetes Mellitus, Type 2 in 1 studies

*Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujiwara, C; Furusawa, Y; Hagaya, M; Kakuta, H; Kawata, K; Kobayashi, T; Kohara, K; Makishima, M; Naitou, H; Nakayama, M; Ohsawa, F; Ohta, Y; Shinozaki, R; Tai, A; Yakushiji, N; Yamada, S; Yasui, H; Yoshikawa, Y1

Other Studies

1 other study(ies) available for 1h-benzotriazole-5-carboxylic acid and Diabetes Mellitus, Type 2

ArticleYear
Mechanism of retinoid X receptor partial agonistic action of 1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-1H-benzotriazole-5-carboxylic acid and structural development to increase potency.
    Journal of medicinal chemistry, 2013, Mar-14, Volume: 56, Issue:5

    Topics: Animals; Chlorocebus aethiops; COS Cells; Diabetes Mellitus, Type 2; Hypoglycemic Agents; Mice; Models, Molecular; Molecular Docking Simulation; Retinoid X Receptors; Tetrahydronaphthalenes; Triazoles

2013